[HTML][HTML] The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review

SL Fishman, H Sonmez, C Basman, V Singh… - Molecular …, 2018 - Springer
Background Traditional risk factors are insufficient to explain all cases of coronary artery
disease (CAD) in patients with diabetes mellitus (DM). Advanced glycation end-products …

Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential …

NL Reynaert, P Gopal, EPA Rutten… - The international journal …, 2016 - Elsevier
Age-related, non-communicable chronic inflammatory diseases represent the major 21st
century health problem. Especially in Western countries, the prevalence of non …

[HTML][HTML] The AGE-RAGE Axis and the Pathophysiology of Multimorbidity in COPD

NL Reynaert, LEGW Vanfleteren… - Journal of Clinical …, 2023 - mdpi.com
Chronic obstructive pulmonary disease (COPD) is a disease of the airways and lungs due to
an enhanced inflammatory response, commonly caused by cigarette smoking. Patients with …

The role of soluble receptor for advanced glycation end-products (sRAGE) in the general population and patients with diabetes mellitus with a focus on renal function …

M Steenbeke, S De Bruyne, M De Buyzere… - Critical Reviews in …, 2021 - Taylor & Francis
Isoforms of the receptor for advanced glycation end-product (RAGE) protein, which lack the
transmembrane and the signaling (soluble RAGE or sRAGE) domains are hypothesized to …

[HTML][HTML] Glyco-oxidation and cardiovascular complications in type 2 diabetes: a clinical update

F Piarulli, G Sartore, A Lapolla - Acta diabetologica, 2013 - Springer
Diabetes is associated with a greatly increased risk of cardiovascular disease (CVD), which
cannot be explained only by known risk factors, such as smoking, hypertension, and …

[HTML][HTML] AGE–RAGE stress and coronary artery disease

K Prasad - International Journal of Angiology, 2021 - thieme-connect.com
Coronary artery atherosclerosis and atherosclerotic plaque rupture cause coronary artery
disease (CAD). Advanced glycation end products (AGE) and its cell receptor RAGE, and …

The role of sRAGE in cardiovascular diseases.

C Delrue, JR Delanghe… - Advances in clinical …, 2023 - europepmc.org
Advanced glycation end products (AGEs), by-products of glucose metabolism, have been
linked to the emergence of cardiovascular disorders (CVD). AGEs can cause tissue damage …

Plasma advanced glycation end products and soluble receptor for advanced glycation end products as indicators of sterol content in human carotid atherosclerotic …

RS Pinto, GS Ferreira, GCR Silvestre… - Diabetes and …, 2022 - journals.sagepub.com
Advanced glycation end products (AGEs) are independently related to cardiovascular
disease (CVD) and favor cholesterol and oxysterol accumulation in macrophage foam cells …

Matrix Metalloproteinase-9 for the Earliest Stage Acute Coronary Syndrome–Comparison With High-Sensitivity Troponin T–

N Kobayashi, N Hata, N Kume, S Yokoyama… - Circulation …, 2011 - jstage.jst.go.jp
Background: Matrix metalloproteinase-9 (MMP-9) is regarded as a biomarker of plaque
rupture or vulnerability and is elevated in patients with acute coronary syndrome (ACS). The …

Soluble receptor for advanced glycation end product: a biomarker for acute coronary syndrome

LJN Jensen, A Flyvbjerg… - BioMed research …, 2015 - Wiley Online Library
The receptor of advanced glycation end products (RAGE) and its ligands are linked to the
pathogenesis of coronary artery disease (CAD), and circulating soluble receptor of …